Sign in
4

Changes in Ownership

ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000012

CEO bought 174,000 shares at an average $0.02 ($3,932)

From the SEC's structured data for this filing

Trades in this filing

Collier Alan Brian · CEO

Table I: Non-derivative

29 lines
Date Transaction Shares Price Value Owned after D/I
2019-02-14 Purchase : show line 1 in the form +5,000 $0.02 $110 21,367,123 D
2019-02-14 Purchase : show line 2 in the form +5,000 $0.02 $110 21,372,123 D
2019-02-14 Purchase : show line 3 in the form +5,000 $0.02 $109 21,377,123 D
2019-02-14 Purchase : show line 4 in the form +10,000 $0.02 $219 21,387,123 D
2019-02-14 Purchase : show line 5 in the form +10,000 $0.02 $219 21,397,123 D
2019-02-14 Purchase : show line 6 in the form +5,000 $0.02 $109 21,402,123 D
2019-02-14 Purchase : show line 7 in the form +5,000 $0.02 $111 21,407,123 D
2019-02-14 Purchase : show line 8 in the form +5,000 $0.02 $110 21,412,123 D
Open-market purchases · 174,000 sh · avg $0.02 · $3,932
Loading xslF345X03/primary_doc.xml…